Skip to main content

Table 6 Strategy changes in patients with ESRD or CKD in the REQUEST study

From: Transit time flow management as a management strategy in high-risk groups undergoing coronary artery bypass grafting

 

Normal renal function (N = 921)

CKD/ESRD (N = 95)

Odds ratio (95% CI)

P-value

 

Any strategy change

224/921 (24.3)

32/95 (33.7)

1.58 (1.01–2.48)

0.047

 

HFUS/TTFM

172/921 (18.7)

25/95 (26.3)

1.56 (0.96–2.53)

0.075

 

Visual/tactile feedback

34/921 (3.7)

10/95 (10.5)

3.08 (1.47–6.43)

0.003

 

Unclassified change

35/921 (3.8)

3/95 (3.2)

0.83 (0.25–2.74)

0.75

 

Changes related to the aorta

     

Any surgical change

69/921 (7.5)

11/95 (11.6)

1.62 (0.74–3.23)

0.16

 

HFUS

64/921 (6.9)

10/95 (10.5)

   

Visual/tactile feedback

3/921 (0.3)

1/95 (1.1)

   

Unclassified change

2/921 (0.2)

0/95 (0.0)

   

Changes related to in situ conduits

     

Any surgical change

14/921 (1.5)

4/95 (4.2)

2.84 (0.67–9.30)

0.079

 

HFUS and/or TTFM

9/921 (1.0)

1/95 (1.1)

   

Visual/tactile feedback

3/921 (0.3)

3/95 (3.2)

   

Unclassified change

2/921 (0.2)

0/95 (0.0)

   

Changes related to coronary targets

     

Any surgical change

98/921 (10.6)

11/95 (11.6)

1.10 (0.51–2.16)

0.73

 

HFUS

66/921 (7.2)

7/95 (7.4)

   

Visual/tactile feedback

10/921 (1.1)

1/95 (1.1)

   

Unclassified change

24/921 (2.6)

3/95 (3.2)

   

Changes related to grafts (per patient)

     

Any surgical change

68/921 (7.4)

11/95 (11.6)

1.64 (0.75–3.28)

0.16

 

HFUS and/or TTFM

44/921 (4.8)

7/95 (7.4)

   

Visual/tactile feedback

20/921 (2.2)

7/95 (7.4)

   

Unclassified change

6/921 (0.7)

0/95 (0.0)

   

Changes related to grafts (per graft)

     

Any surgical change

83/2433 (3.4)

17/242 (7.0)

2.14 (1.17–3.71)

0.008

 

HFUS and/or TTFM

53/2433 (2.2)

9/242 (3.7)

   

Visual/tactile feedback

23/2433 (0.9)

8/242 (3.3)

   

Unclassified change

7/2433 (0.3)

0/242 (0.0)

   
  1. Adapted from Rosenfield et al